Figure 3From: Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donorsOverall survival in patients according to significant univariate analysis parameters. A, IL-8 < 50.7 vs > 50.7 pg/ml. B, IL-12 < 5.2 vs > 5.2 pg/ml.Back to article page